2026年度“北京普惠健康保”特药清单升级至159 种

Core Insights - The 2026 Beijing Inclusive Health Insurance has opened for enrollment in early November, featuring a significant expansion of its special drug list to 159 types, covering 87 diseases [1] Summary by Categories Drug Coverage - The special drug list now includes 57 domestic special drugs and 65 overseas special drugs, with 37 new innovative therapies and high-value chronic disease medications added [1] - The coverage addresses treatment needs for prevalent severe diseases such as leukemia, lymphoma, and lung cancer, including commonly used specialty drugs like Belantamab Mafodotin for leukemia [1] Reimbursement Rates - The reimbursement rate for healthy individuals has increased from 60% to 65%, while for individuals with specific pre-existing conditions, it has risen from 30% to 35% [1] Accessibility and Benefits - Unlike typical commercial insurance, the Beijing Inclusive Health Insurance does not limit enrollment based on health status, allowing individuals with pre-existing conditions to benefit from special drug coverage [1] - The insurance features no deductible and includes direct payment services, addressing challenges related to high medication costs and complex reimbursement processes [1]